Good to see crucial milestone timelines reaffirmed in the half yearly doc:
"Due to the significance of the Mineral Resource increase and upgrade, combined with the advanced level of work being completed, the Company announced in October 2023 that the Bankan Project study had been upgraded from a Scoping Study to a PFS (including maiden Ore Reserves), which will materially improve the level of certainty of the Project. To achieve PFS-level across the entire study, additional work is required in areas such as geotechnical, mine design and cost estimation, and the completion date was therefore revised to Q1 2024 (previously end of 2023 for the Scoping Study). The PFS and the Environmental and Social Impact Assessment continued to progress and remain on track to be completed during Q1 2024."
- Forums
- ASX - By Stock
- Ann: Half Year Accounts
Good to see crucial milestone timelines reaffirmed in the half...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDI (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.3¢ |
Change
0.008(3.06%) |
Mkt cap ! $593.6M |
Open | High | Low | Value | Volume |
24.5¢ | 25.5¢ | 24.5¢ | $340.3K | 1.364M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 369383 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 227458 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 369383 | 0.250 |
15 | 545561 | 0.245 |
10 | 337198 | 0.240 |
5 | 721045 | 0.235 |
18 | 907365 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 227458 | 22 |
0.260 | 114802 | 10 |
0.265 | 85400 | 3 |
0.270 | 62213 | 3 |
0.275 | 55000 | 2 |
Last trade - 14.30pm 13/11/2024 (20 minute delay) ? |
Featured News
PDI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online